Research in Nebraska

More Than 450 Innovative Medicines in Development for Rare Diseases

WASHINGTON, D.C. (October 7, 2013) – America’s biopharmaceutical research companies are developing 452 new medicines for rare diseases, including genetic disorders, neurological conditions, infectious diseases and autoimmune disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Rare Diseases - Big Impact

Medicines in Development for Rare Diseases

Alzheimer's: The Puzzle, The Partners, The Path Forward - Meeting Agenda

Alzheimer’s - The Puzzle, The Partners, The Path Forward

Alzheimer’s Disease (AD) is a debilitating neurodegenerative disease that currently afflicts more than 5 million people in the U.S. In an effort to catalyze progress in AD innovation and R&D, PhRMA, in partnership with the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, is hosting an all-day forum to convene top industry and academic scientists, patients, policymakers, and other stakeholders.

Research in Wisconsin

Research in Florida

Biopharmaceutical Sector Supports Nearly 84,000 Florida Jobs

WASHINGTON, D.C. (September 16, 2013) – Working in collaboration with Florida clinicians and research institutions, America’s biopharmaceutical research companies have conducted more than 7,800 clinical trials of new medicines in Florida over the last 14 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Research in Montana

Pages

Subscribe to RSS - Innovation